Arbital Health, a health tech company focused on value-based care, has secured $31 million in Series B funding, the company announced last week.
The San Francisco-based startup provides infrastructure for payers and providers to help them manage risk-based contracts. Its platform predicts financial outcomes, measures performance across contracts, among other services. It also offers advisory services from a team of actuaries to help clients with the creation and optimization of risk contracts.
Arbital Health’s $31 million Series B round was led by Valtruis and included participation from existing investors Transformation Capital, Shaper Capital and Healthy Ventures. Founded in 2023, the company has raised $46 million in total.
The 3 Best Options to Buy Telemedicine Carts for Neurology Care
Neurologists and health care practitioners must evolve with the world. Telemedicine carts assist in this evolution by serving as an intermediary between patients and doctors.
“Arbital Health has built something the healthcare industry desperately needs: the critical infrastructure that empowers payers and providers to reconcile their risk-based contracts with accelerated performance insights,” said Mike Spadafore, managing director at Valtruis, in a statement. “By combining healthcare’s top actuaries with an advanced, AI-powered platform that automates complex actuarial workflows, Arbital Health is transforming how financial, and performance risk is understood and managed across the system.”
The financing will be used in a few ways, according to Brian Overstreet, Arbital Health’s co-founder and CEO. It will help expand its payer-facing capabilities and “accelerate value-based care contract performance monitoring, management and reconciliation across all major risk models,” he said.
It will also be used to grow its actuarial team and expand its AI-powered platform, he added.
The healthcare industry is increasingly shifting toward value-based care, which links payments to patient outcomes rather than the volume of services provided, as seen in traditional fee-for-service models. However, research shows that while many providers are interested in value-based models, financial and administrative barriers often hold them back.
6 Aesthetic Certification Programs That Include Both Theory and Practical Training
Explore top-tier aesthetic certification programs that blend theory with hands-on training — perfect for health care pros ready to elevate their practice
That’s what Arbital Health hopes to change.
“Value-based care hasn’t succeeded at scale, and that’s not due to a lack of vision or desire,” Overstreet told MedCity News. “The complexity of risk-based contracts, the data fragmentation, and the lack of transparency in settlement has made it difficult for organizations to succeed in value-based care arrangements. There’s been no neutral, trusted infrastructure to centralize contract management, provide real-time visibility, and ensure fair adjudication. That’s where Arbital comes in. We provide payers and providers a centralized platform to manage the full contract ecosystem along with expert insights from a dedicated team of actuaries.”
Ultimately, the company hopes to create “better transparency and create a better vehicle and framework for contracting,” Overstreet added.
Arbital Health isn’t the only company trying to support the transition to value-based care. Others include Syntax Health, Privia Health and Aledade.
Photo: atibodyphoto, Getty Images